课题基金 / 基金详情

A novel lipidic adjuvant carrier system for vaccination including vaccination via the oral route

A novel lipidic adjuvant carrier system for vaccination including vaccination via the oral route
一种用于疫苗接种(包括通过口服途径疫苗接种)的新型脂质佐剂载体系统
批准号:
nhmrc : 102439
负责人:
Prof Istvan Toth
金额:
$14.31万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Prof Istvan Toth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have developed a Lipid-Core-Peptide vaccine adjuvant system, based on the incorporation of lipoamino acids into poly-functional moiety that provides an excellent means for enhancing the antigenicity of a potential peptide-vaccine. As the system contains many variables, which allow substantial modifications to be made, we now wish to fully optimise its structural configuration. A library of spacer-lipoamino acid-poly-functional multiplier systems will be synthesised on solid phase. Model peptide epitopes will be synthesised on these different lipid-core systems and the antibody response will be compared with the response of the model peptide epitopes coupled to conventional vaccine carriers. The Lipid-Core Immunogen constructs including particulate systems will be administered orally as well, followed by measurement of the serum IgG response and the secretory IgA. This novel system can be used for any potential vaccine-peptide epitope and can open a new route to modern vaccination. The specific advantages of these kind of synthetic vaccines include the greater stability of the vaccine, reproducibility, eliminate the use of toxic conventional adjuvants. The key to this system is a novel carrier construct, which is non-toxic and not immunogenic. The system confers immunity with smaller risk of reaction, since it generates antibody production only against the infective microorganism. Vaccination via the oral route is highly desirable since it can overcome many of the disadvantages inherent in administration by injection - e.g. poor patient acceptability, requirement for skilled medical personnel, risk of HIV and other blood-borne diseases, restricted availability and, in cases, stimulation of the wrong type of immunity. Development of vaccines for oral administration will make them much more widely available, permitting self-administration by patients and markedly improving the operation of Public Health vaccination programs, particularly in developing countries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the myometrial transition at term and preterm labour to guide tocolysis
  • 批准号:
    nhmrc : 1126795
  • 项目类别:
    Project Grants
  • 资助金额:
    $55.22万
  • 财政年份:
    2017
  • 负责人:
    Prof Istvan Toth
  • 依托单位:
Development of a multicomponent delivery system for oligonucleotides
  • 批准号:
    DP130100952
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $26.28万
  • 财政年份:
    2013
  • 负责人:
    Prof Istvan Toth
  • 依托单位:
Liposaccharide based peptide and vaccine delivery systems: improving the bioavailability and immunogenicity of Luteinizing Hormone-Releasing Hormone
  • 批准号:
    DP110100212
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $74.07万
  • 财政年份:
    2011
  • 负责人:
    Prof Istvan Toth
  • 依托单位:
Lipid and Carbohydrate Based Systems to Target and Deliver Peptide Drug Candidates to Specific Cells
  • 批准号:
    DP1092829
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $52.26万
  • 财政年份:
    2010
  • 负责人:
    Prof Istvan Toth
  • 依托单位:
海外基金